Literature DB >> 10498617

p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.

E E Cameron1, S B Baylin, J G Herman.   

Abstract

The promoter region of the cyclin-dependent kinase inhibitor p15(INK4B) contains a CpG island that is hypermethylated in many hematologic malignancies. To explore the relationship between patterns of methylation and gene transcription, we used bisulfite genomic sequencing to obtain a detailed analysis of methylation in acute leukemia, leukemia cell lines, and normal lymphocytes. The entire CpG island region of p15 was largely devoid of methylation in normal lymphocytes, but methylation of varying density was found in primary acute leukemia. Methylation density was generally conserved between the alleles from each sample, but marked heterogeneity for the specific CpG sites methylated was observed. Patterns of methylation were compared and expression assessed with reverse-transcriptase polymerase chain reaction (RT-PCR). The density of methylation within the CpG island, and not any specific location, correlates best with transcriptional loss. Leukemias with methylation of approximately 40% of the CpG dinucleotides on each allele had complete gene silencing, with variable, but diminished expression with less dense CpG island methylation. Our results suggest that the transcriptional silencing of p15 in conjunction with aberrant hypermethylation is best understood as an evolutionary process that involves progressively increasing methylation of the entire p15 CpG island.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498617

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.

Authors:  Oliver Galm; Michael R Rountree; Kurtis E Bachman; Kam-Wing Jair; Stephen B Baylin; James G Herman
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.

Authors:  K Sakashita; K Koike; T Kinoshita; M Shiohara; T Kamijo; S Taniguchi; T Kubota
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

4.  Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins.

Authors:  Christopher D Carvin; Rebecca D Parr; Michael P Kladde
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

5.  The tumor suppressor p15Ink4b regulates the differentiation and maturation of conventional dendritic cells.

Authors:  Joanna Fares; Richard Koller; Rita Humeniuk; Linda Wolff; Juraj Bies
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

6.  Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells.

Authors:  Nada Kraguljac Kurtović; Milena Krajnović; Andrija Bogdanović; Nada Suvajdžić; Jelica Jovanović; Bogomir Dimitrijević; Milica Colović; Koviljka Krtolica
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

7.  Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.

Authors:  Dan He; Yi-wang Zhang; Na-na Zhang; Lu Zhou; Jian-ning Chen; Ye Jiang; Chun-kui Shao
Journal:  Med Oncol       Date:  2015-02-27       Impact factor: 3.064

Review 8.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

9.  High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.

Authors:  Marija Balic; Martin Pichler; Jasmin Strutz; Ellen Heitzer; Christoph Ausch; Hellmut Samonigg; Richard J Cote; Nadia Dandachi
Journal:  J Mol Diagn       Date:  2009-01-29       Impact factor: 5.568

Review 10.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.